Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04938180 |
| Title | A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AmMax Bio, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| AmMax Bio Clinical Site | Budapest | Hungary | Details | |||
| AmMax Bio Clinical Site | Warsaw | Poland | Details | |||
| AmMax Bio Clinical Site | Dnipro | Ukraine | Details | |||
| AmMax Bio Clinical Site | Kharkiv | Ukraine | Details | |||
| AmMax Bio Clinical Site | Kyiv | Ukraine | Details |